Optimizing Outcomes for HR+, HER2- Metastatic Breast Cancer
-
Register
- Non-member - Free!
- Member - Free!
You must have an ACCC account in order to register for this course/webinar/webinar series.
If You DO NOT Have An ACCC Account:
- To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
- ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
- OSS at ACCC Members: Please use your state society login credentials.
- Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
- Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
- The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!
If You Have An ACCC Account:
- Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
- You will be automatically redirected back to this course/webinar page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!
PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!
For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.
Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this course/webinar . For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.
This series provides guidance on the optimal management of HR+, HER2- metastatic breast cancer, and is designed for physicians, nurses, pharmacists, physician assistants and other members of the multidisciplinary cancer care team. The series provides an overview of first, second and third line therapies upon disease progression, as well as strategies for managing toxicities and enhancing quality of life for this patient population.
Objectives
By the end of this activity, participants should be able to:
- Discuss evidence-based treatment for patients with HR+, HER2– metastatic breast cancer, including treatment selection strategies
- Outline evaluation and management for patients with potential treatment-related adverse events
- Describe practices that can improve quality of life and clinical outcomes in HR+, HER2– metastatic breast cancer
Dr. Allison Butts, PharmD
Pharmacist Manager- Oncology Pharmacy
UK Healthcare, UK Healthcare Markey Cancer Center, Lexington, KY
Dr. Butts is the oncology pharmacy manager at UK HealthCare and specializes in clinical pharmacy for breast oncology. She received her Bachelor of Science degree in molecular and cellular biology from the University of Illinois at Urbana-Champaign, and her Doctor of Pharmacy degree from the University of Kentucky. She then completed a PGY1 pharmacy practice residency at The Johns Hopkins Hospital and a PGY2 oncology residency at the University of Kentucky Chandler Medical Center. Dr. Butts provides comprehensive pharmaceutical care to patients at the UK Markey Cancer Center, primarily practicing at the Comprehensive Breast Care Center. Additionally, she serves as the PGY2 hematology-oncology pharmacy residency program director and is an assistant adjunct professor at the University of Kentucky College of Pharmacy.
Dr. Pavani Chalasani MD, MPH
Hematologist-Oncologist, Division Director, Hematology-Oncology
George Washington Cancer Center (GWCC), Washington, D.C.
Dr. Chalasani is the director of the hematology-oncology division at the George Washington Cancer Center (GWCC) and co-program lead for the Clinical Translational Oncology Program. After receiving her medical degree from Gandhi Medical College in India, she completed internship, residency and a fellowship in hematology-oncology at the University of Arizona, Tucson. She joined the University of Arizona Cancer Center (UACC) as a faculty member and served as program director for the hematology-oncology fellowship program. Dr. Chalasani is the principal investigator for several clinical trials and was awarded the prestigious NCI Clinical Cancer Investigator Team Leadership Award in 2020. She has received research funding from NIH/NCI, American Cancer Society, Better Than Ever and DOD.
Claudia Y. Franco, PA-C
Physician Assistant
Inova Schar Cancer Institute, Fairfax, VA
Claudia Franco is a certified physician assistant serving at Inova Schar Cancer Institute in Fairfax, VA providing patient care in the outpatient setting. She strives to provide evidence-based compassionate care to patients with medical oncology and hematology needs. Claudia has a passion for community outreach and providing care to underserved patient populations. She serves as a sub-investigator for several clinical trials in breast cancer at Inova and is a member of the Advanced Practitioner Society for Hematology and Oncology.
Complete
Next
Failed
Available
Locked
